Rehabilitation interventions in randomized controlled trials for low back pain: proof of statistical significance often is not relevant

被引:11
作者
Gianola, Silvia [1 ]
Castellini, Greta [1 ,2 ]
Corbetta, Davide [3 ,4 ]
Moja, Lorenzo [1 ,2 ]
机构
[1] IRCCS Ist Ortoped Galeazzi, Unit Clin Epidemiol, Milan, Italy
[2] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
[3] IRCCS San Raffaele Hosp, Rehabil & Funct Recovery Dept, Milan, Italy
[4] Univ Vita Salute San Raffaele, Physiotherapy Degree Course, Milan, Italy
关键词
Epidemiologic methods; Trials; Randomized clinical minimal clinically important difference; Patient outcome assessment; Data interpretation; Statistical; Sample size; SAMPLE-SIZE CALCULATION; CLINICAL IMPORTANCE; FUNCTIONAL STATUS; MINIMAL IMPORTANT; MEDICINE; GUIDELINES; QUALITY; THERAPY; POWER;
D O I
10.1186/s12955-019-1196-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundAn observed statistically significant difference between two interventions does not necessarily imply that this difference is clinically important for patients and clinicians. We aimed to assess if treatment effects of randomized controlled trials (RCTs) for low back pain (LBP) are statistically significant and clinically relevant, and if RCTs were powered to achieve clinically relevant differences on continuous outcomes.MethodsWe searched for all RCTs included in Cochrane Systematic Reviews focusing on the efficacy of rehabilitation interventions for LBP and published until April 2017. RCTs having sample size calculation and a planned minimal important difference were considered. In the primary analysis, we calculated the proportion of RCTs classified as statistically significant and clinically relevant, statistically significant but not clinically relevant, not statistically significant but clinically relevant, and not statistically significant and not clinically relevant. Then, we investigated how many times the mismatch between statistical significance and clinical relevance was due to inadequate power.ResultsFrom 20 eligible SRs including 101 RCTs, we identified 42 RCTs encompassing 81 intervention comparisons. Overall, 60% (25 RCTs) were statistically significant while only 36% (15 RCTs) were both statistically and clinically significant. Most trials (38%) did not discuss the clinical relevance of treatment effects when results did not reached statistical significance. Among trials with non-statistically significant findings, 60% did not reach the planned sample size, therefore being at risk to not detect an effect that is actually there (type II error).ConclusionOnly a minority of positive RCT findings was both statistically significant and clinically relevant. Scarce diligence or frank omissions of important tactic elements of RCTs, such as clinical relevance, and power, decrease the reliability of study findings to current practice.
引用
收藏
页数:8
相关论文
共 26 条
  • [1] Guidelines for the process of cross-cultural adaptation of self-report measures
    Beaton, DE
    Bombardier, C
    Guillemin, F
    Ferraz, MB
    [J]. SPINE, 2000, 25 (24) : 3186 - 3191
  • [2] Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration
    Boutron, Isabelle
    Moher, David
    Altman, Douglas G.
    Schulz, Kenneth F.
    Ravaud, Philippe
    [J]. ANNALS OF INTERNAL MEDICINE, 2008, 148 (04) : 295 - 309
  • [3] Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension
    Calvert, Melanie
    Blazeby, Jane
    Altman, Douglas G.
    Revicki, Dennis A.
    Moher, David
    Brundage, Michael D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 814 - 822
  • [4] Improving Power and Sample Size Calculation in Rehabilitation Trial Reports: A Methodological Assessment
    Castellini, Greta
    Gianola, Silvia
    Bonovas, Stefanos
    Moja, Lorenzo
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2016, 97 (07): : 1195 - 1201
  • [5] What are the implications of optimism bias in clinical research?
    Chalmers, I
    Matthews, R
    [J]. LANCET, 2006, 367 (9509) : 449 - 450
  • [6] Chan KBY, 2001, CAN MED ASSOC J, V165, P1197
  • [7] Patients’, clinicians’ and the research communities’ priorities for treatment research: There is an important mismatch
    Crowe S.
    Fenton M.
    Hall M.
    Cowan K.
    Chalmers I.
    [J]. Research Involvement and Engagement, 1 (1)
  • [8] Challenges and Recommendations for Placebo Controls in Randomized Trials in Physical and Rehabilitation Medicine A Report of the International Placebo Symposium Working Group
    Fregni, Felipe
    Imamura, Marta
    Chien, Hsin Fen
    Lew, Henry L.
    Boggio, Paulo
    Kaptchuk, Ted J.
    Riberto, Marcelo
    Hsing, Wu Tu
    Battistella, Linamara Rizzo
    Furlan, Andrea
    [J]. AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2010, 89 (02) : 160 - 172
  • [9] IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS
    FREIMAN, JA
    CHALMERS, TC
    SMITH, H
    KUEBLER, RR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) : 690 - 694
  • [10] The Quality and Reporting of Randomized Trials in Cardiothoracic Physical Therapy Could Be Substantially Improved
    Geha, Nadia N.
    Moseley, Anne M.
    Elkins, Mark R.
    Chiavegato, Luciana D.
    Shiwa, Silvia R.
    Costa, Leonardo O. P.
    [J]. RESPIRATORY CARE, 2013, 58 (11) : 1899 - 1906